Navigation Links
Curemark Announces Four New Sites Participating in Autism Study
Date:12/2/2010

inal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of protein digestion in children with autism and ADHD. To learn more about our innovative science, visit www.curemark.com

Safe Harbor Statement

This news release contains forward-looking statements that involve risks and uncertainties that could cause our actual results and experiences to differ materially from anticipated results and expectations expressed in such forward-looking statement. These forward-looking statements include, without limitation, statements regarding the mechanism of action of CM-AT, its potential advantages, its potential for use in treating autism, as well as the timing, progress and anticipated results of the clinical development and regulatory processes concerning CM-AT. These statements are based on our current beliefs and expectations as to such future outcomes, and are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. Factors that might cause such a material difference include, among others, risks that the results of clinical trials will not support our claims or beliefs concerning the effectiveness of CM-AT, our ability to finance our development of CM-AT, regulatory risks, and our reliance on third party researchers and other collaborators. We assume no obligation to update these statements, except as required by law.


'/>"/>
SOURCE Curemark LLC
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Curemark Awarded Qualifying Therapeutic Discovery Project (QTDP) Grant
2. Curemark Moderates Autism Panel at Life Sciences Summit 2010
3. Curemark Presents at the Rodman & Renshaw Annual Global Investment Conference
4. James F. Szigethy Named Curemarks Director of New Product Development
5. Curemark to Present at BioPharm America™ 2010
6. Curemark to Present at the Rodman & Renshaw Annual Global Investment Conference
7. Curemark Opens Autism Trials at New Jersey Site
8. Curemark Begins Autism Trials at Two More Sites
9. Dr. Joan Fallon, Curemark CEO, Addresses Keystone Symposia Meeting On Autism
10. Curemark Adds UC Davis MIND Institute to Autism Clinical Trial Sites
11. Curemark CM-AT Autism Treatment Granted FDA Fast Track Status
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... -- STEPh, Inc., a full service medical communications company, ... site ( http://www.stephreports.com ) dedicated to investigational ... Reports STEPh Reports are comprehensive critical reviews ... Report assesses the competitive landscape by individual drug monograph, ... specific key issues.  STEPh Reports are written by individuals ...
(Date:5/22/2013)... Minn. , May 22, 2013 /PRNewswire/ ... the successful completion of its global Phase ... an internally developed program for the management ... proprietary formulation technology.  USL255 is specifically engineered ... fluctuations in topiramate blood levels observed with ...
(Date:5/22/2013)... 2013 MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would ... some recent company developments. As Medifirst continues to expand ... with shareholders. Integrating social media into its investor relations ... will post updates on Twitter.  The Facebook homepage is ... Says CEO Bruce J. Schoengood ...
Breaking Medicine Technology:Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Medifirst Solutions, Inc. Announces Update To Shareholders 2
(Date:5/23/2013)... 2013 Long-Term Care Insurance shopping ... rate at which applicants for Long Term Care Insurance are ... , The decision to buy a Long Term Care ... willing and able to purchase protection are increasingly being turned ... any price. A variety of chronic conditions appear to ...
(Date:5/23/2013)... AttorneyOne.com, a recognized authority on law, ... providing expert opinion in view of the recent news ... to court documents, on March 5, 2013 a woman ... no. 3:2013cv50102) alleging that her husband suffered massive brain ... is mainly used as a blood thinner for patients ...
(Date:5/22/2013)... St. Petersburg, FL (PRWEB) May 23, 2013 ... rarely affects men due to several factors, including estrogen ... Cellulite is essentially toxins and fatty deposits stored and ... skin. "To diminish cellulite, one must take a multi-pronged ... These multi-pronged actions include: , Specific products like ...
(Date:5/22/2013)... research shows that bicyclists who wear helmets have an ... at Boston Children,s Hospital found that simply having bicycle ... in deaths and injuries for children younger than 16 ... The cross-sectional study, conducted by William P. Meehan III, ... MD, MPH of Boston Children,s Hospital, and Christopher M. ...
(Date:5/22/2013)... Dr. Andrew Satlin offers patients with ... the Laser Assisted New Attachment Procedure (LANAP). May is Stroke ... connections between gum disease and stroke. Periodontal disease is one ... today, and is linked to an increased risk for strokes ... infected gum pockets. , Periodontal disease is essentially an ...
Breaking Medicine News(10 mins):Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 3Health News:New Lawsuit on Pradaxa Brain Hemorrhage: Now, AttorneyOne Can Provide Advice 2Health News:Get Cellulite Under Control Now with Cellulite Whisperer® Products Introduced by Sublime Beauty® 2Health News:Rate of bicycle-related fatalities significantly lower in states with helmet laws 2Health News:For Stroke Awareness Month, Dr. Andrew Satlin is Raising Awareness of the Connections Between Gum Disease and Stroke and Offers Encino, CA Laser Gum Surgery for Treatment 2
... 2008VANCOUVER, April 20 /PRNewswire-FirstCall/ - Response Biomedical Corporation ... revenues for the three-month period ended March 31, ... $2.526 million compared to $1.173 million for the ... revenues for any quarter in the Company,s history ...
... Intervention Will Retain Decision Resources, Clinical Gold Standard ... from Decision ResourcesWALTHAM, Mass., April 20 Decision ... advisory firms for pharmaceutical and healthcare issues, finds ... mortality as the attribute that most influences their ...
... Friends , BURLINGTON, Mass. , April 20 ... known for allergy-friendly desserts and snacks, is pleased to ... character whose TV show entertains kids while providing insight ... of growing up. Launched in 2004, Cherrybrook Kitchen has ...
... N.J., April 20 UNICO National, the largest Italian ... to announce its 2009 Award recipients. The Awardees will ... in Lake Las Vegas, NV this July. Americanism ... Award Alan Krutchkoff, Fairlawn, NJFounder of the ...
... to The Leukemia & Lymphoma SocietyWHITE PLAINS, N.Y., April 20 ... that mothers perform on behalf of their children and other ... do something special to pay tribute to mothers.Consider the heroic ... is nothing more terrifying for a mother than to watch ...
... love Scent To Sleep products so much, we bought ... (ICP) announced today that ICP has acquired Scent To ... and distributes a revolutionary All Natural Non-Drowsy Sleep Mist ... love Scent To Sleep products so much, we bought ...
Cached Medicine News:Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 2Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 3Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 4Health News:For Reducing Mortality, Current and Emerging Therapies Have No Advantage Over Carvedilol in the Treatment of Coronary Heart Disease (Stable Angina) 2Health News:For Reducing Mortality, Current and Emerging Therapies Have No Advantage Over Carvedilol in the Treatment of Coronary Heart Disease (Stable Angina) 3Health News:Cherrybrook Kitchen Announces New Partnership With Arthur 2Health News:Cherrybrook Kitchen Announces New Partnership With Arthur 3Health News:UNICO National Announces 2009 Award Winners 2Health News:UNICO National Announces 2009 Award Winners 3Health News:This Mother's Day Celebrate a Mother's Love 2Health News:Scent To Sleep All Natural Non-Drowsy Sleep Mist Acquired by Innovative Custom Products, Inc. (ICP) 2
... GORE-TEX Stretch Vascular Grafts have met ... vascular procedures. Recognized for exceptional performance ... endorsement of renowned surgeons worldwide. These ... and the spread of infection, and ...
... GORE-TEX INTERING Vascular Graft, the newest vascular ... Associates, a leader in vascular surgical products ... performance by reducing kinking and compression ... This new graft provides all of the ...
... GORE-TEX INTERING Vascular Graft, the newest vascular ... Associates, a leader in vascular surgical products ... performance by reducing kinking and compression ... This new graft provides all of the ...
... EpochXP Workstations provide comprehensive neurological monitoring ... care unit to accurately access your ... over 15 years experience, and a ... EpochXP neurological monitoring systems have a ...
Medicine Products: